slotkoers
Andere beurzen
|
||
- USD | - |
07/05 | Transcript : Aclaris Therapeutics, Inc., Q1 2024 Earnings Call, May 07, 2024 | |
07/05 | Aclaris Therapeutics, Inc. rapporteert resultaten voor het eerste kwartaal dat eindigde op 31 maart 2024 | CI |
Vakgebied
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Therapeutics
90,3
%
| 25 | 85,2 % | 28 | 90,3 % | +11,27% |
Contract Research
9,7
%
| 17 | 57,2 % | 3 | 9,7 % | -82,15% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 30 | 100,0 % | 31 | 100,0 % | +5,03% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Neal Walker
CEO | Chief Executive Officer | 54 | 01-07-12 |
Kevin Balthaser
DFI | Director of Finance/CFO | 37 | 01-01-17 |
Ajay Aggarwal
CTO | Chief Tech/Sci/R&D Officer | - | 01-10-21 |
Joseph Monahan
CTO | Chief Tech/Sci/R&D Officer | 69 | 01-08-17 |
General Counsel | - | 01-06-18 | |
James Loerop
PRN | Corporate Officer/Principal | 60 | 31-01-22 |
Elaine Morefield
PRN | Corporate Officer/Principal | - | - |
Corporate Officer/Principal | - | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Andrew Schiff
BRD | Director/Board Member | 58 | 09-08-17 |
Maxine Gowen
BRD | Director/Board Member | 66 | 02-07-19 |
Director/Board Member | 60 | 07-01-20 | |
Director/Board Member | 57 | 01-09-16 | |
Neal Walker
CEO | Chief Executive Officer | 54 | 01-07-12 |
Anand Mehra
BRD | Director/Board Member | 48 | 01-09-14 |
Director/Board Member | 58 | 01-09-14 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 71 264 786 | 69 452 534 ( 97,46 %) | 0 | 97,46 % |
Bedrijfsgegevens
Sector
Verkoop per activiteit
Vaira. 1 jan. | Kapi. | |
---|---|---|
+49,45% | 56,95 mld. | |
+39,98% | 40,26 mld. | |
-7,49% | 39,32 mld. | |
-4,42% | 28,37 mld. | |
+11,96% | 26,45 mld. | |
-18,07% | 19,41 mld. | |
+28,93% | 12,54 mld. | |
+25,62% | 12,21 mld. | |
-1,39% | 12,15 mld. |
- Beurs
- Aandelen
- Koers ACRS
- Koers
- Onderneming ACLS THER